SCHEMBL2230498

SCHEMBL2230498

CC(=O)c1cccc2c1N(CCCCBr)C(=O)CC2(C)C

nearest known ligand 0.36

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
HTR1A P08908 3/20 0.36
DRD2 P14416 3/20 0.36
HTR7 P34969 2/20 0.36
HTR2C P28335 1/20 0.36
HRH1 P35367 1/20 0.36
HTR2B P41595 1/20 0.36
HDAC1 Q13547 2/20 0.33
HDAC6 Q9UBN7 2/20 0.33
DRD3 P35462 1/20 0.32
HDAC2 Q92769 2/20 0.32
NOTUM Q6P988 1/20 0.32
HDAC3 O15379 1/20 0.31
HDAC4 P56524 1/20 0.31
HDAC8 Q9BY41 1/20 0.31
HDAC9 Q9UKV0 1/20 0.31
SCN1A P35498 1/20 0.31
SCN2A Q99250 1/20 0.31
SCN3A Q9NY46 1/20 0.31
HTR2A P28223 2/20 0.31
ALDH1A1 P00352 2/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL2231425 0.88 HTR1A (0.36) HTR1ADRD2HTR7HTR2CHRH1
SCHEMBL9682204 0.79 NOTUM (0.35) DRD2HTR2CHTR2BHDAC1HDAC6
SCHEMBL1764398 0.76 HTR1A (0.44) HTR1ADRD2HTR7HTR2CHRH1
SCHEMBL1764037 0.75 HDAC1 (0.47) HTR1ADRD2HTR7HTR2CHRH1
SCHEMBL8556355 0.66 HTR1A (0.55) HTR1ADRD2HTR7HTR2CHRH1
SCHEMBL10559978 0.65 NOTUM (0.44) NOTUM
SCHEMBL1764561 0.65 HDAC1 (0.48) HDAC1HDAC6HDAC2HDAC3HDAC4
SCHEMBL6769139 0.65 HDAC1 (0.46) HDAC1HDAC6HDAC2HDAC3HDAC4
SCHEMBL4427655 0.65 HDAC1 (0.46) HDAC1HDAC6HDAC2HDAC3HDAC4
SCHEMBL6765782 0.65 HDAC1 (0.46) HDAC1HDAC6HDAC2HDAC3HDAC4

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1751116-B1 Pyrimidine compounds and use thereof in the treatment of central nervous system disorders ABBOTT GMBH & CO KG (DE) 2013-07-31 EP disclosed
EP-2361908-A1 Pyrimidine compounds useful for the treatment of CNS diseases Abbott GmbH & Co. KG (DE) 2011-08-31 EP disclosed